These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8139451)
41. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent. Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407 [TBL] [Abstract][Full Text] [Related]
42. Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues. Vitha T; Kubícek V; Kotek J; Hermann P; Vander Elst L; Muller RN; Lukes I; Peters JA Dalton Trans; 2009 May; (17):3204-14. PubMed ID: 19421622 [TBL] [Abstract][Full Text] [Related]
43. Gadolinium(III) complexes of 1,4,7-triazacyclononane based picolinate ligands: simultaneous optimization of water exchange kinetics and electronic relaxation. Nonat A; Giraud M; Gateau C; Fries PH; Helm L; Mazzanti M Dalton Trans; 2009 Oct; (38):8033-46. PubMed ID: 19771367 [TBL] [Abstract][Full Text] [Related]
44. Mn2+ complexes with 12-membered pyridine based macrocycles bearing carboxylate or phosphonate pendant arm: crystallographic, thermodynamic, kinetic, redox, and 1H/17O relaxation studies. Drahoš B; Kotek J; Císařová I; Hermann P; Helm L; Lukeš I; Tóth É Inorg Chem; 2011 Dec; 50(24):12785-801. PubMed ID: 22092039 [TBL] [Abstract][Full Text] [Related]
45. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats. Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826 [TBL] [Abstract][Full Text] [Related]
46. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087 [TBL] [Abstract][Full Text] [Related]
48. Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity. Borel A; Helm L; Merbach AE Chemistry; 2001 Feb; 7(3):600-10. PubMed ID: 11261657 [TBL] [Abstract][Full Text] [Related]
49. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging. Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439 [TBL] [Abstract][Full Text] [Related]
51. Phosphonate-modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue-specific contrast agents. Adzamli IK; Blau M Magn Reson Med; 1991 Jan; 17(1):141-8. PubMed ID: 2067390 [TBL] [Abstract][Full Text] [Related]
53. A gadolinium triacetic monoamide DOTA derivative with a methanethiosulfonate anchor group. Relaxivity properties and conjugation with albumin and thiolated particles. Thonon D; Jacques V; Desreux JF Contrast Media Mol Imaging; 2007; 2(1):24-34. PubMed ID: 17286333 [TBL] [Abstract][Full Text] [Related]
54. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion. Lancelot E Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546 [TBL] [Abstract][Full Text] [Related]
55. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity. Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598 [TBL] [Abstract][Full Text] [Related]
56. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats. Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311 [TBL] [Abstract][Full Text] [Related]
57. In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications. de Sousa PL; Livramento JB; Helm L; Merbach AE; Même W; Doan BT; Beloeil JC; Prata MI; Santos AC; Geraldes CF; Tóth E Contrast Media Mol Imaging; 2008; 3(2):78-85. PubMed ID: 18412106 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin. Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062 [TBL] [Abstract][Full Text] [Related]
59. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282 [TBL] [Abstract][Full Text] [Related]
60. Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs. Geraldes CF; Brown RD; Brucher E; Koenig SH; Sherry AD; Spiller M Magn Reson Med; 1992 Oct; 27(2):284-95. PubMed ID: 1334203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]